跳至主要内容
临床试验/ISRCTN82353628
ISRCTN82353628已完成不适用

Disabling fatigue in multiple sclerosis occurs frequently : How should it be treated? A randomized clinical trial

VU University Medical Center (Netherlands)0 个研究点目标入组 90 人开始时间: 2011年7月19日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • Ambulatory multiple sclerosis (MS) patients fulfulling the following enrollment criteria:
  • 1. Age between 18-70 years
  • 2. Diagnosis of MS according to the criteria of McDonald
  • 3. Able to walk with no more than one unilateral walking aid i.e. able to walk with no more than one unilateral walking aid
  • 4. Suffering from fatigue, defined as a score higher than 35 on the subscale fatigue of the Checklist Individual Strength (CIS)

排除标准

  • 1. Patients using in the last three months prior to inclusion amantadine, modafinil, Ritalin®
  • or pemoline for their fatigue
  • 2. Major depression

研究者

发起方
VU University Medical Center (Netherlands)

相似试验